View all stories with this category.
Derek Lowe considers the problems of addressing drug development out of sequence
Derek Lowe worries that mergers are upsetting the balance of the pharmaceutical ecosystem
How important is it to have the best equipped lab, wonders Derek Lowe
Derek Lowe discusses the age-old tradition of passing the buck
Derek Lowe ponders the likelihood of arriving where he started
Testing times for Derek Lowe
Derek Lowe seeks a cure for 'compound bloat'
Derek Lowe remembers leaving the ivory towers of academe to trade 'unusual and beautiful' for 'useful'
Derek Lowe is looking for a little more variety among his reactions
Derek Lowe says this is no time to be an 'ordinary' scientist
Derek Lowe dreams of the day when chemists and biologists can understand each other
Derek Lowe wonders what lessons we can learn from the Vytorin fiasco
The recent row over antidepressants reminds us how little we know about the brain, says Derek Lowe
Derek Lowe wonders how to revive some lost techniques
It's been a rough year, but the future looks bright, says Derek Lowe
Derek Lowe squares up to the challenge of biologics
Chemists are finally going with the flow, says Derek Lowe
The high cost of energy has an unexpected benefit, says Derek Lowe - it forces us to be more efficient
Will Phase Zero trials actually help drug development, wonders Derek Lowe
Process chemists just don't get the credit they deserve, says Derek Lowe
© Royal Society of Chemistry Registered charity number: 207890
Site powered by Webvision Cloud